VANDA PHARMACEUTICALS INC. (VNDA)
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
Veradigm Launches Health Network Architecture to Level the Playing Field for Independent Practices
Symbotic Reports Second Quarter Fiscal Year 2026 Results
Nortech Systems Incorporated to Report First Quarter 2026 Financial Results and Hold a Conference Call on May 14, 2026
Warner Bros. Discovery Reports First Quarter 2026 Results
Cirrus Logic Reports Fourth Quarter Revenue of $448.5 Million and Record Full Fiscal Year 2026 Revenue of $2.0 Billion
REGAL REXNORD REPORTS STRONG FIRST QUARTER 2026 FINANCIAL RESULTS
Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements
Events and transactions